for the Period Ended 28 February 2024
Balance sheet | |
Additional notes | |
Community Interest Report |
As at
Notes | 13 months to 28 February 2024 | ||
---|---|---|---|
|
£ |
||
Current assets | |||
Cash at bank and in hand: |
|
||
Total current assets: |
|
||
Net current assets (liabilities): |
|
||
Total assets less current liabilities: |
|
||
Total net assets (liabilities): |
|
||
Capital and reserves | |||
Called up share capital: |
|
||
Total Shareholders' funds: |
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 28 February 2024
Basis of measurement and preparation
for the Period Ended 28 February 2024
13 months to 28 February 2024 | ||
---|---|---|
Average number of employees during the period |
|
The company attended local events set up to educate the public on the correct pathways to obtain a legal medical cannabis prescription. We spoke with patients who were interested in obtaining a prescription but needed help in following the correct procedures to stay on the right side of the law. This also included assisting with the laws around having a prescription in the workplace, Driving with a prescription and travelling abroad with a prescription
The companny's stakeholders are the Director and patients that have been assisted in helping them make a more informed decision on their medications. At the end of our assistance we ask the patients if there is anything with the service that needs to be adjusted to make the service more streamlined as many of the patients have lifelong disabilities. This helps the company be more inclusive to those who might need it most.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
16 October 2024
And signed on behalf of the board by:
Name: Matthew Mitchell Stuart Ross
Status: Director